mda-7/IL24 kills pancreatic cancer cells by inhibition of the Wnt/PI3K signaling pathways:: Identification of IL-20 receptor-mediated bystander activity against pancreatic cancer

被引:62
作者
Chada, S [1 ]
Bocangel, D
Ramesh, R
Grimm, EA
Mumm, JB
Mhashilkar, AM
Zheng, MZ
机构
[1] Introgen Therapeut, Houston, TX 77030 USA
[2] Univ Texas, MD Anderson Canc Ctr, Dept Thorac & Cardiovasc Surg, Houston, TX 77030 USA
[3] Univ Texas, MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA
关键词
MDA-7; beta-catenin; apoptosis; IL-24; adenovirus; cancer gene therapy; IL-10; IL-20; IL-22; receptor;
D O I
10.1016/j.ymthe.2004.12.021
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The melanoma differentiation-associated gene (mda-7, approved gene symbol IL24) is a tumor suppressor gene whose protein expression in normal cells is restricted to the immune system and to melanocytes. Recent studies have shown that mda-7 gene transfer inhibits cell growth and induces apoptosis in melanoma, lung cancer, breast cancer, and other tumor types through activation of various intracellular signaling pathways. In the current study, we demonstrate that Ad-mda7 transduction of human pancreatic cancer cells results in G(2)/M cell cycle arrest and cell killing. Cytotoxicity is mediated via apoptosis in a time- and dose-dependent manner. Tumor and cell killing correlates with regulation of proteins involved in the Wnt and PI3K pathways: beta-catenin, APC, GSK-3, JNK, and PTEN. Additionally, we identify bystander cell killing activated by exposure of pancreatic tumor cells to secreted human MDA-7 protein. In pancreatic tumor cells, exogenous MDA-7 protein activates STAT3 and kills cells via engagement of IL-20 receptors. The specificity of bystander killing is demonstrated using neutralizing anti-MDA-7 antibodies and anti-receptor antibodies, which inhibit the apoptotic effects. In sum, we show that Ad-mda7 is able to induce growth inhibition and apoptosis in pancreatic cancer cells via inhibition of the Wnt/PI3K pathways and identify a novel bystander mechanism of MDA-7 killing in pancreatic cancer that functions via IL-20 receptors.
引用
收藏
页码:724 / 733
页数:10
相关论文
共 45 条
  • [1] Interleukin 20: Discovery, receptor identification, and role in epidermal function
    Blumberg, H
    Conklin, D
    Xu, WF
    Grossmann, A
    Brender, T
    Carollo, S
    Eagan, M
    Foster, D
    Haldeman, BA
    Hammond, A
    Haugen, H
    Jelinek, L
    Kelly, JD
    Madden, K
    Maurer, MF
    Parrish-Novak, J
    Prunkard, D
    Sexson, S
    Sprecher, C
    Waggie, K
    West, J
    Whitmore, TE
    Yao, L
    Kuechle, MK
    Dale, BA
    Chandrasekher, YA
    [J]. CELL, 2001, 104 (01) : 9 - 19
  • [2] The protein product of the tumor suppressor gene, melanoma differentiation-associated gene 7, exhibits immunostimulatory activity and is designated IL-24
    Caudell, EG
    Mumm, JB
    Poindexter, N
    Ekmekcioglu, S
    Mhashilkar, AM
    Yang, XHH
    Retter, MW
    Hill, P
    Chada, S
    Grimm, EA
    [J]. JOURNAL OF IMMUNOLOGY, 2002, 168 (12) : 6041 - 6046
  • [3] Bystander activity of Ad-mda7: Human MDA-7 protein kills melanoma cells via an IL-20 receptor-dependent but STAT3-independent mechanism
    Chada, S
    Mhashilkar, AM
    Ramesh, R
    Mumm, JB
    Sutton, RB
    Bocangel, D
    Zheng, MZ
    Grimm, EA
    Ekmekcioglu, S
    [J]. MOLECULAR THERAPY, 2004, 10 (06) : 1085 - 1095
  • [4] MDA-7/IL-24 is a unique cytokine-tumor suppressor in the IL-10 Family
    Chada, S
    Sutton, RB
    Ekmekcioglu, S
    Ellerhorst, J
    Mumm, JB
    Leitner, WW
    Yang, HY
    Sahin, AA
    Hunt, KK
    Fuson, KL
    Poìndexter, N
    Roth, JA
    Ramesh, R
    Grimm, EA
    Mhashilkar, AM
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2004, 4 (05) : 649 - 667
  • [5] Clinical and local biological effects of an intraturnoral injection of mda-7 (IL24; INGN 241) in patients with advanced carcinoma:: a phase I study
    Cunningham, CC
    Chada, S
    Merritt, JA
    Tong, A
    Senzer, N
    Zhang, Y
    Mhashilkar, A
    Parker, K
    Vukelja, S
    Richards, D
    Hood, J
    Coffee, K
    Nemunaitis, J
    [J]. MOLECULAR THERAPY, 2005, 11 (01) : 149 - 159
  • [6] Cutting edge: STAT activation by IL-19, IL-20 and mda-7 through IL-20 receptor complexes of two types
    Dumoutier, L
    Leemans, C
    Lejeune, D
    Kotenko, SV
    Renauld, JC
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 167 (07) : 3545 - 3549
  • [7] Reciprocal enhancement of gene transfer by combinatorial adenovirus transduction and plasmid DNA transfection in vitro and in vivo
    Dunphy, EJ
    Redman, RA
    Herweijer, H
    Cripe, TP
    [J]. HUMAN GENE THERAPY, 1999, 10 (14) : 2407 - 2417
  • [8] Down-regulated melanoma differentiation associated gene (MDA-7) expression in human melanomas
    Ekmekcioglu, S
    Ellerhorst, J
    Mhashilkar, AM
    Sahin, AA
    Read, CM
    Prieto, VG
    Chada, S
    Grimm, EA
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2001, 94 (01) : 54 - 59
  • [9] Loss of MDA-7 expression with progression of melanoma
    Ellerhorst, JA
    Prieto, VG
    Ekmekcioglu, S
    Broemeling, L
    Yekell, S
    Chada, S
    Grimm, EA
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (04) : 1069 - 1074
  • [10] Inhibition of AKT abrogates chemotherapy-induced NF-κB survival mechanisms:: Implications for therapy in pancreatic cancer
    Fahy, BN
    Schlieman, MG
    Virudachalam, S
    Bold, RJ
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2004, 198 (04) : 591 - 599